The Lancet Respiratory Medicine

Journal Name: The Lancet Respiratory Medicine

Journal Type: Q1

ISSN: 22132600, 22132619

Country: United Kingdom

Subject Area and Category: Medicine Pulmonary and Respiratory Medicine

Publisher: Elsevier Ltd

Research Ranking: 13

Publication Type: Journals

H-Index: 197

Coverage: 2013-2025

Editors-in-Chief: Emma Grainger

Research Impact Score: 55.3

Impact Factor: 102.642

SCIMAGO SJR: 6.788

APC Cost: $6,300

Homepage: https://www.thelancet.com/journals/lanres/onlineFirst

Submission Link: https://www.thelancet.com/journals/lanres/home

Contact Email: https://ees.elsevier.com/thelancetrm/default.asp?acw=54d1507e3c6a6744b71aa071217ccc9280bcgxrqaDDF5860D7A58A3684F36433CE89C824BAD74A95C88794FBFD4FB551350B1AC7BCF55F53C8EA53DE5C81661A51902A4855CC4B479994D2BC63FBA44D1BD4E4F2EB0469A67597464825D387A21AFA2E514&utt=9e11b404547a361f556e673-af40724dfeba0cdb-l2

Address: 7, Adam Street, Adelphi, W.C.2

Overview

The Lancet Respiratory Medicine is one of the most prestigious and impactful journals dedicated to respiratory health and critical care. As part of the globally recognized Lancet family of medical journals, it delivers high-quality, peer-reviewed content that shapes clinical practice and advances scientific understanding in the fields of pulmonology, intensive care, and sleep medicine.

Founded to address the growing challenges in respiratory diseases, The Lancet Respiratory Medicine offers a wide range of research articles, reviews, commentaries, and clinical trials. It plays a pivotal role in disseminating critical knowledge about conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, lung cancer, and emerging respiratory infections like COVID-19. The journal is especially known for publishing groundbreaking studies on ventilatory support, respiratory physiology, and public health strategies aimed at mitigating the global burden of respiratory diseases.

One of the key strengths of The Lancet Respiratory Medicine lies in its editorial integrity and rigorous peer-review process. The journal consistently ranks among the top respiratory journals globally, with a high impact factor and wide readership among clinicians, researchers, and policy makers. Its commitment to evidence-based medicine ensures that all published articles are of the highest scientific and ethical standards.

In addition to original research, the journal is known for its influential reviews and expert commentaries. These pieces provide in-depth insights into current trends, clinical challenges, and future directions in respiratory medicine. Topics often cover multidisciplinary aspects of care, incorporating insights from immunology, oncology, cardiology, and critical care, making the journal a valuable resource for a broad spectrum of healthcare professionals.

SEO keywords such as “top respiratory medicine journal,” “clinical research in pulmonology,” “Lancet Respiratory Medicine impact factor,” and “updates on lung disease treatments” reflect the journal’s relevance and search demand in both academic and clinical settings. It also serves as a vital reference for medical educators and trainees who seek up-to-date content backed by scientific rigor.

The journal has also taken a leadership role in addressing global health issues. During the COVID-19 pandemic, The Lancet Respiratory Medicine provided rapid and reliable updates on diagnostic techniques, treatment protocols, and long-term respiratory consequences of the virus. Its timely publications contributed significantly to public health policy and global treatment strategies.

About

The Lancet Respiratory Medicine is a highly respected, peer-reviewed medical journal that focuses exclusively on respiratory medicine, critical care, and sleep medicine. Launched in 2013, this journal is part of the prestigious Lancet family, known globally for its high-impact scientific publications. With a strong reputation for publishing groundbreaking clinical research, expert reviews, and insightful commentary, The Lancet Respiratory Medicine plays a vital role in shaping the future of respiratory healthcare.

Leading the Way in Respiratory Research

As one of the top-ranked journals in the field of pulmonary and respiratory health, The Lancet Respiratory Medicine publishes original research articles that have the potential to transform clinical practice. The journal covers a wide range of topics, including asthma, chronic obstructive pulmonary disease (COPD), lung cancer, pulmonary fibrosis, tuberculosis, pneumonia, and acute respiratory distress syndrome (ARDS).

During the COVID-19 pandemic, The Lancet Respiratory Medicine became a go-to source for timely, accurate, and evidence-based information. It published critical studies on ventilation strategies, long COVID, vaccine efficacy in respiratory patients, and the evolving burden on intensive care units.

Trusted by Healthcare Professionals and Researchers Worldwide

Clinicians, researchers, policymakers, and healthcare professionals across the globe rely on The Lancet Respiratory Medicine for its rigorous editorial standards and commitment to scientific integrity. The journal maintains a strict peer-review process, ensuring that each article meets the highest standards of accuracy and relevance.

The journal is indexed in major databases such as PubMed, Scopus, and Web of Science, increasing its visibility and citation potential. With a high impact factor, it is a preferred platform for authors seeking to share novel insights and findings in the respiratory medicine field.

Key Features of The Lancet Respiratory Medicine:

High-Quality Research: Publishes original studies, clinical trials, meta-analyses, and systematic reviews.
Expert Opinion: Offers commentaries and viewpoints from leading figures in respiratory medicine.
Global Reach: Readership includes specialists and institutions in over 100 countries.
Multidisciplinary Focus: Covers not only pulmonology but also critical care, sleep medicine, immunology, and infectious disease as related to respiratory health.

A Platform for Innovation and Collaboration

The Lancet Respiratory Medicine also plays a key role in fostering collaboration among clinicians, researchers, and healthcare organizations. It supports continuous medical education through its comprehensive review articles and case studies, helping professionals stay up to date with the latest developments in diagnosis, treatment, and policy-making.

Scope

The Lancet Respiratory Medicine is a globally renowned, peer-reviewed journal dedicated to advancing research, education, and clinical practice in the field of respiratory medicine. As part of The Lancet family of journals, it stands at the forefront of publishing high-impact studies, systematic reviews, and commentaries that shape the understanding and treatment of respiratory diseases worldwide.

Focus Areas and Coverage

The journal's scope encompasses a wide range of topics within respiratory medicine, with a strong emphasis on both clinical and translational research. Key focus areas include:

Chronic Obstructive Pulmonary Disease (COPD)
Asthma and Allergy
Lung Cancer
Interstitial Lung Diseases
Pulmonary Hypertension
Cystic Fibrosis
Sleep-Disordered Breathing
Critical Care and Intensive Care Medicine
Infectious Diseases such as tuberculosis and pneumonia
Global Respiratory Health Challenges, including air pollution and tobacco use

The journal also addresses emerging respiratory threats such as COVID-19 and other novel respiratory pathogens, making it a crucial platform for timely and evidence-based updates.

Commitment to High-Quality Research

The Lancet Respiratory Medicine maintains rigorous editorial standards to ensure that all published content reflects scientific integrity and clinical relevance. The journal features original research articles, meta-analyses, case studies, and expert opinion pieces, often accompanied by insightful editorials that contextualize findings within the broader medical landscape.

Each manuscript undergoes a meticulous peer-review process, attracting contributions from leading researchers, clinicians, and public health experts around the world.

Global Impact and Influence

The journal has a strong international presence and a high impact factor, which reflects its significant influence in shaping clinical guidelines and respiratory health policies. By fostering collaboration across borders, The Lancet Respiratory Medicine contributes to a more unified approach to diagnosing, managing, and preventing respiratory diseases on a global scale.

Its readership includes pulmonologists, intensivists, allergists, thoracic surgeons, epidemiologists, and healthcare policy makers, making it an essential resource for professionals seeking to stay abreast of the latest developments in the field.

Advancing Public Health and Innovation

In addition to traditional research areas, the journal frequently explores innovative therapies, digital health solutions, and interdisciplinary approaches to patient care. It plays a pivotal role in addressing disparities in respiratory health, advocating for equitable access to care, and highlighting the social determinants of health that influence respiratory outcomes.